Dementia today seems so unbeatable that organizers of this year’s Alzheimer’s Association International Conference put only a few cure-related items in a special collection of documents.
At press time, the list of official conference news releases included two with headlines that referred to indicators that correlate with rapid cognitive decline, two with headlines that referred to the MetLife Foundation, and just one that referred to possible treatments for Alzheimer’s.
The conference highlighted a press release about a Lewin Group analysis suggesting that 28 million of the 70 million baby boomers will develop Alzheimer’s disease, and that, by 2040, those boomers with Alzheimer’s will account for $328 billion in Medicare spending, in 2014 dollars, or about 24 percent of all 2040 Medicare spending.
On Sunday, a panel of researchers discussed whether the world should shift research dollars away from search for methods for detecting and curing Alzheimer’s, and toward controlling risk factors, such as poor nutrition, and improving support for people who already have dementia.
From the perspective of conference organizers, just coming up with basic research suggesting that doctors could, eventually, get better tools for determining who will develop severe dementia, looked like great news.
Of course, the insurance companies that protect consumers against health care and long-term care (LTC) care costs, their policyholders, and their agents and brokers want more than tools for assessing the prognosis of the case of dementia, or announcements that MetLife Foundation is generously supporting efforts to honor dementia researchers. Insurers, consumers and producers want the researchers to come up with products for preventing and treating Alzheimer’s.
Researchers solved the insurance community’s tuberculosis problem, and then the polio problem. Now, the target is dementia.
For a look at some hints researchers gave of possible ways to prevent or cure Alzheimer’s, read on.
The body uses calcium to build bones and cells use calcium to send signals to one another.
Grace Stutzmann talked on Sunday about research showing that brain cells affected by Alzheimer’s disease have trouble handling calcium long before other symptoms of the condition appear.
Coming up with drugs that improve the way brain cells handle calcium might be a way to prevent Alzheimer’s symptoms from appearing, Stutzmann said.